Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06049758
NA

D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy

Sponsor: General Committee of Teaching Hospitals and Institutes, Egypt

View on ClinicalTrials.gov

Summary

Evaluating the differences between D2 and D3 lymphadenectomy in laparoscopic right hemicolectomy in patients with right cancer colon post-operative outcome, intra-operative blood transfusion, post-operative ICU admission, anastomotic leakage, lymph node harvesting in the final specimen, and six months follow up and overall survival time after 5-years

Official title: D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy In Right Cancer Colon Patients: A Randomized Controlled Trial

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2024-01-02

Completion Date

2030-01-02

Last Updated

2023-09-22

Healthy Volunteers

Yes

Interventions

PROCEDURE

LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (intervention)

Patients with right-side colon cancer (caecum, ascending, or hepatic flexure); were diagnosed by CT entero-colonography, colonoscopy, and biopsy who undergo laparoscopic right hemicolectomy

DRUG

Enoxaparin 40 Mg/0.4 mL Injectable Solution

Enoxaparin sodium 40 mg subcutaneous injection will be administered 12 hours before the operation

DRUG

Levofloxacin 500mg

Levofloxacin 500 mg intravenous injection will be administered 1 hour before the operation.

PROCEDURE

LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (Conventional)

Patients with right-side colon cancer (caecum, ascending, or hepatic flexure); were diagnosed by CT entero-colonography, colonoscopy, and biopsy who undergo laparoscopic right hemicolectomy

Locations (1)

The surgical department of Medical Research Institute Hospital, Alexandria University

Alexandria, Egypt